Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks

oleh: Michael Migden, MD, Carmen Loquai, MD, PhD, Caroline Robert, MD, PhD, Jean-François Baurain, MD, PhD, Nicholas Squittieri, MD, Ramon Arntz, Dr, Jörg Dierlamm, BSc, Brigitte Dréno, MD, PhD